Association of heart rate and outcomes in a broad spectrum of patients with chronic heart failure: Results from the CHARM (Candesartan in Heart Failure: Assessment of Reduction in Mortality and morbidity) program

Journal of the American College of Cardiology

Volumn 59, Issue 20, 2012, Pages 1785-1795

  Castagno, Davide ^a,b   Skali, Hicham ^a   Takeuchi, Madoka ^a   Swedberg, Karl ^c   Yusuf, Salim ^d   Granger, Christopher B ^e   Michelson, Eric L ^f   Pfeffer, Marc A ^a   McMurray, John J V ^a,g   Solomon, Scott D ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b UNIVERSITY OF TURIN   (Italy)

^c UNIVERSITY OF GOTHENBURG   (Sweden)

^d HAMILTON HEALTH SCIENCES   (Canada)

^e DUKE UNIVERSITY MEDICAL CENTER   (United States)

^f ASTRAZENECA   (United Kingdom)

^g UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

atrial fibrillation; ejection fraction; heart failure; heart rate; prognosis

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CANDESARTAN; DIGITALIS GLYCOSIDE; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; PLACEBO; SPIRONOLACTONE;

ADULT; AGED; ARTICLE; CARDIOVASCULAR MORTALITY; CONTROLLED STUDY; DRUG DOSE INCREASE; FEMALE; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART RATE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC);

AGED; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; BENZIMIDAZOLES; FEMALE; HEART FAILURE; HEART RATE; HUMANS; MALE; MIDDLE AGED; MORBIDITY; TETRAZOLES; TREATMENT OUTCOME;

EID: 84860738847     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2011.12.044     Document Type: Article

References (29)

1. K. Fox, J.S. Borer, A.J. Camm Heart Rate Working Group Resting heart rate in cardiovascular disease J Am Coll Cardiol 50 2007 823 830 (Pubitemid 47277500)
2. P. Lechat, J.S. Hulot, S. Escolano Heart rate and cardiac rhythm relationship with bisoprolol benefit in chronic Heart failure in CIBIS II trial Circulation 103 2001 1428 1433 (Pubitemid 32220636)
3. K. Fox, I. Ford, P.G. Steg BEAUTIFUL Investigators Heart rate as a prognostic risk factor in patients with coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a subgroup analysis of a randomised controlled trial Lancet 372 2008 817 821
4. M. Ahmadi-Kashani, D.J. Kessler, J. Day INTRINSIC RV Study Investigators Heart rate predicts outcomes in an implantable cardioverter-defibrillator population Circulation 120 2009 2040 2045
5. E.L. Fosbol, M. Seibaek, B. Brendorp Danish Investigations and Arrhythmia ON Dofetilide Study Group Long-term prognostic importance of resting heart rate in patients with left ventricular dysfunction in connection with either heart failure or myocardial infarction: the DIAMOND study Int J Cardiol 140 2010 279 286
6. M. Böhm, K. Swedberg, M. Komajda Heart rate as a risk factor in chronic heart failure (SHIFT): the association between heart rate and outcomes in a randomised placebo-controlled trial Lancet 376 2010 886 894
7. L.A. Mulieri, G. Hasenfuss, B. Leavitt, P.D. Allen, N.R. Alpert Altered myocardial force-frequency relation in human heart failure Circulation 85 1992 1743 1750
8. K. Swedberg, M. Komajda, M. Böhm SHIFT Investigators Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study Lancet 376 2010 875 885
9. Task Force for Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of European Society of Cardiology ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008 Eur Heart J 29 2008 2388-42
10. S.A. Hunt, W.T. Abraham, M.H. Chin 2009 focused update incorporated into the ACC/AHA 2005 guidelines for the diagnosis and management of heart failure in adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines developed in collaboration with the International Society for Heart and Lung Transplantation J Am Coll Cardiol 53 2009 e1 e90
11. W.H. Maisel, L.W. Stevenson Atrial fibrillation in heart failure: epidemiology, pathophysiology, and rationale for therapy Am J Cardiol 91 2003 2D 8D (Pubitemid 36369329)
12. M.A. Pfeffer, K. Swedberg, C.B. Granger CHARM Investigators and Committees Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme Lancet 362 2003 759 766 (Pubitemid 37093915)
13. K. Swedberg, M.A. Pfeffer, C.B. Granger CHARM-Programme Investigators Candesartan in heart failure - assessment of reduction in mortality and morbidity (CHARM): rationale and design J Card Fail 5 1999 276 282 (Pubitemid 29449267)
14. J.J. McMurray, J. Ostergren, M.A. Pfeffer CHARM Investigators and Committees Clinical features and contemporary management of patients with low and preserved ejection fraction heart failure: baseline characteristics of patients in the Candesartan in Heart Failure-Assessment of Reduction in Mortality and Morbidity (CHARM) programme Eur J Heart Fail 5 2003 261 270 (Pubitemid 37011854)
15. C.B. Granger, J.J. McMurray, S. Yusuf CHARM Investigators and Committees Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial Lancet 362 2003 772 776 (Pubitemid 37093917)
16. J.J. McMurray, J. Ostergren, K. Swedberg CHARM Investigators and Committees Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial Lancet 362 2003 767 771 (Pubitemid 37093916)
17. S. Yusuf, M.A. Pfeffer, K. Swedberg CHARM Investigators and Committees Effects of candesartan in patients with chronic heart failure and preserved left ventricular systolic function: the CHARM-Preserved trial Lancet 362 2003 777 781 (Pubitemid 37093918)
18. J. Cuzick A Wilcoxon-type test for trend Stat Med 4 1985 87 90 (Pubitemid 15142530)
19. S.J. Pocock, D. Wang, M.A. Pfeffer CHARM investigators Predictors of mortality and morbidity in patients with chronic heart failure Eur Heart J 27 2006 65 75 (Pubitemid 41785934)
20. M.T. Maeder, D.M. Kaye Differential impact of heart rate and blood pressure on outcome in patients with heart failure with reduced versus preserved left ventricular ejection fraction Int J Cardiol 155 2012 249 256
21. J.R. Kapoor, P.A. Heidenreich Heart rate predicts mortality in patients with heart failure and preserved systolic function J Card Fail 16 2010 806 811
22. V. Bertomeu-González, J. Núñez, E. Núñez Heart rate in acute heart failure, lower is not always better Int J Cardiol 145 2010 592 593
23. M. Rienstra, I.C. Van Gelder, M.P. Van den Berg A comparison of low versus high heart rate in patients with atrial fibrillation and advanced chronic heart failure: effects on clinical profile, neurohormones and survival Int J Cardiol 109 2006 95 100
24. J.N. Cohn, T.B. Levine, M.T. Olivari Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure N Engl J Med 311 1984 819 821
25. P.F. Binkley, E. Nunziata, G.J. Haas, S.D. Nelson, R.J. Cody Parasympathetic withdrawal is an integral component of autonomic imbalance in congestive heart failure: demonstration in human subjects and verification in a paced canine model of ventricular failure J Am Coll Cardiol 18 1991 464 472
26. J.E. Atwood, J. Myers, M. Sullivan Maximal exercise testing and gas exchange in patients with chronic atrial fibrillation J Am Coll Cardiol 11 1988 508 513 (Pubitemid 18060208)
27. R. Pop-Busui Cardiac autonomic neuropathy in diabetes: a clinical perspective Diabetes Care 33 2010 434 441
28. K. Narkiewicz, P.J. van de Borne, M. Hausberg Cigarette smoking increases sympathetic outflow in humans Circulation 98 1998 528 534 (Pubitemid 28371250)
29. R. Wang, S.W. Lagakos, J.H. Ware, D.J. Hunter, J.M. Drazen Statistics in medicine - reporting of subgroup analyses in clinical trials N Engl J Med 357 2007 2189 2194